Preclinical evaluation of the POLY-ADP ribose polymerase 1 (PARP-1) inhibitor AG014699 in combination with topotecan and temozolomide for the treatment of medulloblastoma and neuroblastoma

  1. Lookup NU author(s)
  2. Professor Steven Clifford
  3. Rachel Daniel
  4. Agata Rozanska
  5. Huw Thomas
  6. Professor Alan Boddy
  7. Professor Deborah Tweddle
  8. Professor Nicola Curtin
Author(s)Clifford S, Daniel R, Rozanska A, Thomas HD, Boddy AV, Tweddle DA, Curtin NJ
Editor(s)
Publication type Conference Proceedings (inc. Abstract)
Conference Name39th International Conference of the International Society for Pediatric Oncology
Conference LocationNational Centre for Performing Arts, Mumbai, India
Year of Conference2007
Date31-10-2007 - 03-11-2007
Volume49
Pages434-435 O.133
1545-5009
ISBN
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
PublisherPediatric Blood and Cancer
URLhttp://dx.doi.org/10.1002/pbc.21342
DOI10.1002/pbc.21342
Actions    Link to this publication
Share
Library holdingsSearch Newcastle University Library for this item